Elsevier

The Spine Journal

Volume 5, Issue 2, March–April 2005, Pages 191-201
The Spine Journal

Review Article
Epidural steroid therapy for back and leg pain: mechanisms of action and efficacy

https://doi.org/10.1016/j.spinee.2004.10.046Get rights and content

Abstract

Background context

Epidural steroid injection (ESI) is one of the most common nonsurgical interventions prescribed for back and leg pain symptoms. Although the use of ESI is widespread, proof of efficacy among the broad population of low back pain patients is lacking and use is predicated to a great extent on the cost and morbidity of the perceived “next step” in many patient's care—surgery.

Purpose

To review the relative indications and clinical features that predict success with ESI therapy, and to provide a physiological rationale to guide clinical decision-making.

Study design/setting

Review of literature and clinical experience.

Results

Clinical studies have alternately supported and refuted the efficacy of ESI in the treatment of patients with back and leg pain. Steroid medications do benefit some patients with radicular pain, but the benefit is often limited in duration, making efficacy difficult to prove over time. Steroids appear to speed the rate of recovery and return to function, however, allowing patients to reduce medication levels and increase activity while awaiting the natural improvement expected in most spinal disorders. Fluoroscopic verification of needle placement, with contrast injection, greatly improves steroid delivery while reducing risks. Although it is assumed that the benefit of steroids is related to their effect on inflammation, that remains unproven, and it is possible that benefit is gained through an unrecognized action.

Conclusions

Randomized, controlled trials are needed to conclusively identify those patients most likely to benefit from ESI, and when and for how long. Until then, epidural steroids provide a reasonable alternative to surgical intervention in selected patients with back and/or leg pain, whose symptoms are functionally limiting. When appropriate goals are established and proper patients are selected, sufficient short-term benefit has been documented to warrant continued use of this tool.

Introduction

Whereas mechanical compression of the spinal nerve root is usually the precipitating cause of sciatic pain in patients with lumbar disc herniation, it is unlikely that pressure on the nerve root is the only cause of radicular pain in patients with disc disease [1], [2], [3]. The association between pressure and pain is not so direct. Severe nerve root compression may not produce pain in every patient, and surgical decompression may fail to relieve symptoms in others. Although decompression may provide more rapid improvement than nonsurgical care, nonoperative modalities can provide excellent pain relief in many patients [4], [5]. The key factor determining the extent and severity of leg and back pain in these patients is often inflammation, in combination with nerve root pressure or mechanical irritation. Modalities that alleviate this inflammatory process can reduce pain symptoms and improve function in patients with a variety of spinal disorders.

Section snippets

History of epidural steroid use

Medications were first injected into the epidural space to treat back and leg pain in the early part of the last century. Viner began injecting large volumes of saline and procaine into the lumbar epidural space to treat back pain and lumbar radiculopathy in the 1920s [6]. Evans reported results with a similar procedure in 1930, but achieved only a 14% clinical success rate in 40 patients [7]. The effects of epidural steroid injection were first reported in 1960. Brown reported complete

Causes of sciatica

Nerve root compression, through disc herniation or stenosis, is the most common cause of sciatic pain symptoms [17], [18], [19]. Other factors contribute significantly to the overall experience of radicular pain, however. Although Lindblom and Rexed proposed nerve root compression as a cause of radicular pain after demonstrating pathological changes in nerve roots compressed by herniated disc material [20], other investigators have revealed disc protrusion or herniation on post-mortem

Scientific rationale for corticosteroid use

Lindahl and Rexed first noted inflammation, edema, and proliferative or degenerative changes in biopsy samples from posterior nerve roots of patients undergoing laminectomy [29]. Berg, using myelography, observed a consistent reduction in the swelling of involved nerve roots coincident with improvement in the patient's sciatic symptoms [30]. Green [31] reported a similar improvement in a patient treated with intramuscular dexamethasone.

In 1990, Saal et al. demonstrated an immunocompetent

Clinical effectiveness

Proving that steroid injections are effective has been difficult. Systematic reviews (such as the Cochrane Collaboration) depend on high-quality randomized controlled studies for data, putting emphasis on the methods and criteria of the studies selected. Clinical studies of epidural steroid therapy have, by and large, suffered from one or more of the following flaws:

  • 1)

    Lack of appropriate controls;

  • 2)

    Lax treatment protocols, introducing a variety of concurrent therapies along with the epidural

Causes of treatment failure

Considering the inconsistent outcomes reflected in these studies, surprisingly little has been said about factors predisposing patients to failure of epidural steroid therapy. Although psychosocial factors have long been recognized with respect to surgical and overall outcomes, only a few studies have specifically addressed these issues with respect to epidural injections.

Jamison et al. identified four factors that predicted a poor outcome among patients with chronic low back pain [80]: 1)

What constitutes an adequate epidural injection?

Treatment approaches vary from center to center, but some basic principles are generally observed. As in any treatment of spine patients, patient selection often dictates the likelihood of success. For the most part, epidural steroid therapy should be reserved for patients with symptoms of radiculopathy. Even then, patients with radicular symptoms resulting from spinal stenosis are less likely to benefit than those with disc herniation [77]. Patients with diabetes, or with any signs of

Transforaminal epidural injection

In the transforaminal approach, a smaller gauge blunt needle is used to introduce the steroid into the epidural space via the intervertebral foramen [93]. This technique allows placement of pharmacological agent very close to the irritated nerve root. Unlike the translaminar approach, transforaminal epidural injections have been considered the most advantageous in reaching the ventral thecal sac, the cardinal site of the pathology. The procedure is done with the patient in prone position and

Summary

Clinical studies have alternately supported and refuted the efficacy of epidural steroids in the treatment of patients with back and leg pain. Groups studied have had mixed pathologies, some of which present no inflammatory component on which steroids might be expected to act.

Steroid medications do benefit some patients with radicular pain, but the benefit is often limited in duration, making efficacy difficult to prove over time. Steroids appear to speed the rate of recovery and return to

References (95)

  • A.H. White

    Injection techniques for the diagnosis and treatment of low back pain

    Orthop Clin North Am

    (1983)
  • J.T. Davidson et al.

    Epidural injections in the lumbosciatic syndrome

    Br J Anaesth

    (1961)
  • G.E. Lutz et al.

    Fluoroscopic transforaminal lumbar epidural steroids: an outcome study

    Arch Phys Med Rehabil

    (1998)
  • N. Hayashi et al.

    The effect of epidural injection of betamethasone or bupivacaine in a rat model of lumbar radiculopathy

    Spine

    (1998)
  • K. Olmarker

    Spinal nerve root compression: nutrition and function of the porcine cauda equina compressed in vivo

    Acta Orthop Scand

    (1991)
  • B.A. Winkelstein et al.

    Mechanical thresholds for initiation and persistence of pain following nerve root injury: mechanical and chemical contributions at injury

    J Biomech Eng

    (2004)
  • A. Hakelius

    Prognosis in sciatica

    Acta Orthop Scand

    (1970)
  • H. Weber

    Lumbar disc herniation: a controlled prospective study with ten years observation

    Spine

    (1980)
  • N. Viner

    Intractable sciatica: the sacral epidural injection—an effective method of giving relief

    Can Med Assoc J

    (1925)
  • J.H. Brown

    Pressure caudal anaesthesia and back manipulation

    Northwest Med (Seattle)

    (1960)
  • H.W. Goebert et al.

    Sciatica: treatment with epidural injections of procaine and hydrocortisone

    Cleveland Clinic Quart

    (1960)
  • K.D. Riew et al.

    The effect of nerve-root injections on the need for operative treatment of lumbar radicular pain: a prospective, randomized, controlled, double-blind study

    J Bone Joint Surg Am

    (2000)
  • G. Heyse-Moore

    A rational approach to the use of epidural medication in the treatment of sciatic pain

    Acta Orthop Scand

    (1978)
  • M. Swerdlow et al.

    A study of extradural medication in the relief of the lumbosciatic syndrome

    Anaesthesia

    (1970)
  • D.A. Nelson et al.

    Complications from intrathecal steroid therapy in patients with multiple sclerosis

    Acta Neurol Scand

    (1973)
  • C.N. Shealy

    Dangers of spinal injections without proper diagnosis

    J Am Med Assoc

    (1966)
  • M. Roberts et al.

    Tuberculous meningitis after intrathecally administered methylprednisolone acetate

    J Am Med Assoc

    (1967)
  • R. Derby et al.

    Response to steroid and duration of radicular pain as predictors of surgical outcome

    Spine

    (1992)
  • M. Cornefjord et al.

    Neuropeptide changes in compressed spinal nerve roots

    Spine

    (1995)
  • B. Rydevik et al.

    Pathoanatomy and pathophysiology of nerve root compression

    Spine

    (1984)
  • K. Lindblom et al.

    Spinal nerve injury in dorsolateral protrusions of lumbar disks

    J Neurosurg

    (1948)
  • D.L. McRae

    Asymptomatic intervertebral disc protrusions

    Acta Radiol

    (1956)
  • W.E. Hitselberger et al.

    Abnormal myelograms in asymptomatic patients

    J Neurosurg

    (1968)
  • S.D. Boden et al.

    Abnormal magnetic resonance scans of the lumbar spine in asymptomatic subjects

    J Bone Joint Surg

    (1990)
  • J.M. Cavanaugh

    Neural mechanisms of lumbar pain

    Spine

    (1994)
  • T. Takebayashi et al.

    Effect of nucleus pulposus on the activity of dorsal root ganglion

    Spine

    (2001)
  • J.F. Howe

    A neurophysiological basis for the radicular pain of nerve root compression

  • R.W. Murphy

    Nerve roots and spinal nerves in degenerative disc disease

    Clin Orthop

    (1977)
  • O. Lindahl et al.

    Histological changes in spinal nerve roots of operated cases of sciatica

    Acta Orthop Scand

    (1950)
  • A. Berg

    Clinical and myelographic studies of conservatively treated cases of lumbar intervertebral disc protrusion

    Acta Chir Scand

    (1953)
  • L.N. Green

    Dexamethasone in the management of symptoms due to herniated lumbar disc

    J Neurol Neurosurg Psychiatry

    (1975)
  • Saal JS, Sibley R, Dobrow R, Reynolds J, Saal JA, White AH. Cellular response to lumbar disc herniations: an...
  • W. Pruzanski et al.

    Secretory synovial fluid phospholipase A2 and its role in the pathogenesis of inflammation in arthritis

    J Rheumatol

    (1989)
  • P. Vadas et al.

    The pro-inflammatory effect of intraarticular injection of soluable human and venom phospholipase A2

    Am J Pathol

    (1989)
  • R.C. Franson et al.

    Human disc phospholipase A2 is inflammatory

    Spine

    (1992)
  • J.S. Saal et al.

    High levels of inflammatory phospholipase A2 activity in lumbar disc herniations

    Spine

    (1990)
  • J.N. Weinstein et al.

    The pain of discography

    Spine

    (1988)
  • Cited by (142)

    View all citing articles on Scopus

    FDA device/drug status: not applicable.

    Nothing of value received from a commercial entity related to this research.

    View full text